PrognomiQ
PrivateLast Round
Series D
Nov 5, 2024
Total Funding Raised
$135M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PrognomiQ is a biotechnology company that develops multi-omics diagnostic test products for the early detection and treatment of cancer and other complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrognomiQ Comparables
Compare PrognomiQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delfi Diagnostics | 86% | |
| Biodesix Inc | 81% | |
| Harbinger Health | 80% | |
PrognomiQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 5, 2024 | ||||
| Series C | Mar 15, 2022 | ||||
| Series B | Sep 15, 2020 |
Key People
Founding team and executive leadership
PrognomiQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Ventures | Series C, Series B |
| Fidelity Management & Research Company | Series C, Series B |
| Catalio Capital Management | Series C, Series D |
| Invus Opportunities | Series C |
| T. Rowe Price | Series C, Series B |
| aMoon | Series C, Series D, Series B |
| Wing Venture Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 40% MoM, reaching 4.1K.
- Nov 18, 2025
Launched ProVue Lung, a blood test for early lung cancer detection.
PrognomiQ Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PrognomiQ's valuation, stock price, and market status.